Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 38, 2024 - Issue 1
Submit an article Journal homepage
14
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Letter to the Editor concerning ‘cost-effectiveness of velmanase alfa vs. bone marrow transplantation or no causal therapy in patients with mild to moderate alpha-mannosidosis’

A. L. Stevensona Health Economics and Outcomes Research, Global Rare Diseases, Chiesi Ltd, Manchester, UKCorrespondence[email protected]
View further author information
,
S. Chang-Douglassb Modeling & Simulation, Evidence Synthesis, Modeling and Communication, Evidera Ltd, London, UKView further author information
,
P. Kazmierskab Modeling & Simulation, Evidence Synthesis, Modeling and Communication, Evidera Ltd, London, UKView further author information
,
A. Benedictc Scientific Affairs, Modeling & Simulation, Evidence Synthesis, Modeling and Communication, Evidera Ltd, Budapest, HungaryView further author information
,
K. Azimpourd Health Economics and Outcome Research, Chiesi Canada Corp, Montreal, CanadaView further author information
&
P. Dorlinge Head of Health Economics Outcome Research & Real World Evidence, Rare Diseases, Chiesi USA, Inc, Boston, MA, USAView further author information
Article: 2386487 | Published online: 01 Aug 2024

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.